UDIBI

Published: September 6, 2022 In Vitro and In Vivo Characterization of a Broadly Neutralizing Anti-SARS-CoV-2 Antibody Isolated from a...

Validation of an ADCC assay using human primary natural killer cells to evaluate biotherapeutic products bearing an Fc región....

Published: april 10, 2019 CD80 Expression Correlates with IL-6 Production in THP-1-Like Macrophages Costimulated with LPS and Dialyzable Leukocyte...

Published: August 28, 2022 Evolution of Anti-SARS-CoV-2 Therapeutic Antibodies More information

An international comparative analysis and roadmap to sustainable biosimilar markets. SHOW MORE

Taking advantage of a high-throughput flow cytometer for the implementation of an ADCC assay for regulatory compliance. SHOW MORE

Efficacy, Pharmacokinetics, and Toxicity Profiles of Broad Anti-SARS-CoV-2 Neutralizing Antibody. SHOW MORE

Published : March 2021 Poor survival in COVID-19 associated with Lymphopenia and Higher Neutrophile-Lymphocyte ratio More information